Johnson & Johnson agrees to acquire Abbott Medical Optics for $4.325bn in cash
Johnson & Johnson has agreed to acquire Abbott Medical Optics, a subsidiary of Abbott Laboratories, for $4.325bn in cash.
AMO, which reported sales of $1.1bn for 2015, has ophthalmic products in cataract surgery, laser refractive surgery and consumer eye health segments, including solutions and eye drops.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here